ESC Professional Premium Access

When is the time to implement novel biomarkers routinely?

Event: ESC Congress 2022
Topic: Biomarkers
Session type: Advances in Science
Date: 26 August 2022
Time: 14:00 - 15:15

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

State of the art lecture - when is the time to implement novel biomarkers routinely?

Speaker: Professor B. Ference (Cambridge, GB)
Thumbnail

Plasma amyloid-beta levels and risk of new-onset atrial fibrillation in the general population

Speaker: Mr Z. Lu (Rotterdam, NL)
Thumbnail

Association of fatal and non-fatal adverse health outcomes with urinary peptides reflecting collagen I turnover

Speaker: Doctor J. Melgarejo (Leuven, BE)
Thumbnail

Panel discussion.

Thumbnail

3 speakers from this session

Professor Brian A Ference

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)
27 presentations
3 followers

Mr Zuolin Lu

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
0 follower

Doctor Jesus Melgarejo

KU Leuven, Leuven (Belgium)
0 follower

This platform is supported by

logo Novo Nordisk